Second Chance for Moms Act

The Second Chance for Moms Act (HR 796) requires a new warning label on mifepristone - a medication used for medical abortions - stating that natural progesterone may counteract its effects and increase fetal survival, with a hotline reference for further information. It also mandates a federal 24/7 hotline providing support and referrals exclusively to healthcare providers offering "abortion pill reversal" services. This bill directly affects patients prescribed mifepristone and healthcare providers who dispense the medication, as the label must appear on packaging and the hotline must be established. The warning label would take effect six months after enactment, and the hotline would operate under the Public Health Service Act.